Juvena Therapeutics
juvenatherapeutics.com
Actively hiring
Regenerative Medicine
Cell & Gene Therapy
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$34.8M
2 rounds on record
Latest round
$30.5M
Series B · Jun 2025 · 15 mo ago
Team
28
US Form 5500 (plan participants) · Dec 2025 · +17% in a year
Backers
1
Compound
The money's age
Due for its next round
15 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 17
New executive Juvena Therapeutics Appoints Julie Anne Smith as Chief Executive Officer · morningstar.com
2025
Team of 28 was 24 · US Form 5500 (plan participants)
Jun 27, 2025
Raised a round Series B $30.5M · SEC Form D
Feb 7, 2018
Raised a round Venture round $4.3M · SEC Form D
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Jun 2025 | $30.5M | — | SEC Form D |
| Venture round | Feb 2018 | $4.3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Juvena Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Hanadie YousefExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Compound Similar startupsby what they do, their industry and backers
High purity, bioactive recombinant cytokine proteins and growth factors made for stem cell, organoid and regenerative medicine.
Conception combines stem cell biology and engineering to create new possibilities for having children.
Your stem cells will never be younger than they are today. Bank them now at their peak for a lifetime of physician-directed regenerative…
Cellino is a Massachusetts biotechnology company founded in 2017. It automates stem cell manufacturing with laser editing, imaging and…
Discover Regenerative Medicine with D&P Bioinnovations. Transformative solutions for healing damaged tissues. Call us.
Acorn is a personalized regenerative medicine company, helping people preserve their own cells to prepare for the future of cell-based…
News
Juvena Therapeutics: $33.5 Million Series B Raised To Advance Regenerative Biologics Pipeline
Juvena Therapeutics announced it has raised $33.5 million in a Series B financing to advance its clinical-stage regenerative biologics programs and expand its AI-enabled discovery capabilities.
Read more
Report
Report
Juvena Therapeutics Announces Initiation of First-in-Human Clinical Trial of JUV-161
JUV-161 is a first-in-class muscle regenerating biologic that will address myopathies starting with Myotonic Dystrophy Type 1 JUV-161 was discovered using Juvena's proprietary JuvNET platform, an AI and stem cell secretome-based drug discovery and develop
Read more
Report
Pro access
Upgrade to see all 6 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Hanadie Yousef
Executive Officer, Director
Steven James
Director
Ben Hemani
Director
Stephen Juelsgaard
Director
Laura Lande-Diner
Director
Christopher Kirk
Director
Ayman AlAbdallah
Director
Jeremy O'Connell
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
San Mateo
United States
HQ
Redwood City
United States
Regional office
640 Galveston Drive, Redwood City, CA, 94063, US